From November 17 to 20, 2025, the world-renowned MEDICA exhibition will take place in Düsseldorf, Germany, traditionally bringing together leading medical industry professionals from more than 70 countries worldwide. During the exhibition, we will showcase a wide range of high-quality in vitro diagnostic products, including ELISA test kits and components for their [...]
Our team is pleased to introduce matched pairs of monoclonal antibodies specifically targeting surface lipoproteins of Mycoplasma hominis. Designed for high-affinity binding, these antibodies enable sensitive and specific detection in urogenital clinical samples. They are ideally suited for developers of diagnostic tests and research-use-only (RUO) tools focused on reproductive tract infections. [...]
Vitrotest has developed new matched pairs of monoclonal antibodies specific to Giardia lamblia cyst antigens. These antibodies are ideal for use in sandwich immunoassays such as ELISA and rapid tests. They are optimized for use in diagnostic and research assays, and will be of particular interest to manufacturers of in vitro diagnostic [...]
Vitrotest is pleased to announce the expansion of its product portfolio with the introduction of recombinant Protein G. This streptococcal surface protein from Group G is widely used in immunological applications. It serves as an effective tool for the development of affinity purification carriers for antibodies, as well as for conjugation and [...]
From 11 to 14 November 2024 MEDICA will once again bring together international medical experts from more than 70 countries in Düsseldorf, Germany. Vitrotest Group will once again present high-quality and innovative products at the exhibition. Vitrotest® consistently strives to push the boundaries of scientific research and development in the field of [...]
Vitrotest is proud to announce the launch of its latest innovation, HIV -1 Recombinant Proteins p24, designed to enhance HIV-1 Ab detection efforts. These advanced proteins contain immunodominant regions specific to HIV-1, making it highly effective for detecting antibodies to the virus in clinical and research settings. With its precision and reliability, [...]
Company Vitrotest has introduced new monoclonal antibodies designed to specifically detect tumor marker HE4 (human epididymis protein 4), a crucial indicator in ovarian cancer. These antibodies are optimized for immunoenzyme assays, enhancing the accuracy of cancer diagnostics by precisely binding to this marker. This product represents a key advancement in diagnostic tools, [...]
Vitrotest has unveiled an improved website with an advanced search system designed to provide a smoother user experience. This upgrade includes a comprehensive product catalog featuring their entire range, ensuring customers can easily access detailed information about every item. The company's commitment to customer satisfaction is evident in these enhancements, which aim to [...]
Vitrotest is thrilled to announce its participation in the renowned MEDICA 2023 in Düsseldorf, one of the world's largest medical B2B trade fairs. We will showcase our cutting-edge offerings, including ELISA test systems and vital components for their production, such as monoclonal antibodies, recombinant and native antigens, controls, and reagents. You can [...]
The range of Vitrotest products includes tests for the diagnosis of Parasites, Infections, Allergies, Tumor markers and others. Our products contain a significant intellectual and innovative component. High sensitivity and specificity have been verified on commercial panels and NIBSC standards. We have made every effort to ensure that the testing process is as [...]
